Geron Corporation Email Format
Biotechnology ResearchCalifornia, United States201-500 Employees
Geron is a biotechnology company focused on developing therapies for blood cancers. It received FDA approval for the first telomerase inhibitor indicated for certain adults with lower-risk myelodysplastic syndromes who rely on transfusions. The firm is the only company with an oligonucleotide telomerase inhibitor approved by the FDA. Its research program extends to other hematologic malignancies, including a pivotal Phase 3 trial in relapsed/refractory myelofibrosis after prior JAK-inhibitor therapy. The company is based in Foster City, California, and in 2026 announced leadership changes, including the appointment of Timothy Williams as Executive Vice President and Chief Legal Officer.